See more : Bangchak Sriracha Public Company Limited (BSRC.BK) Income Statement Analysis – Financial Results
Complete financial analysis of Body and Mind Inc. (BMMJ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Body and Mind Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- WinPro Industries Limited (WINPRO.NS) Income Statement Analysis – Financial Results
- Erste Group Bank AG (EBKOF) Income Statement Analysis – Financial Results
- Shin-Etsu Chemical Co., Ltd. (4063.T) Income Statement Analysis – Financial Results
- Pan Asia Data Holdings Inc. (1561.HK) Income Statement Analysis – Financial Results
- Fennec Pharmaceuticals Inc. (FENC) Income Statement Analysis – Financial Results
Body and Mind Inc. (BMMJ)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.bodyandmind.com
About Body and Mind Inc.
Body and Mind Inc. cultivates, processes, distributes, and retails medical and recreational cannabis in Nevada, California, Arkansas, Ohio, and Michigan in the United States. The company offers packaged and grinded flower buds; concentrates; Gpen vaporizers; distillate oil cartridges; and distillate infused edible products. It also produces and sells medical and adultuse recreational marijuana products, such as cannabis flower, oil, extracts, and edibles under the Body and Mind brand name. In addition, the company operates ShowGrow San Diego dispensary; and manages ShowGrow Long Beach dispensary. Further, it produces marijuana extract products, such as distillate oils, ice waxes, dry sifts, shatters, edibles, and topicals. The company was formerly known as Deploy Technologies Inc. and changed its name to Body and Mind Inc. in November 2017. Body and Mind Inc. was incorporated in 1998 and is headquartered in Vancouver, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 22.82M | 31.64M | 25.70M | 5.29M | 4.61M | 2.41M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 17.04M | 20.69M | 13.71M | 3.78M | 2.83M | 1.22M | 1.68K | 6.67K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 5.78M | 10.94M | 11.99M | 1.51M | 1.78M | 1.20M | -1.68K | -6.67K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 25.31% | 34.59% | 46.65% | 28.53% | 38.61% | 49.57% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 835.33K | 669.47K | 282.87K | 449.95K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 11.15M | 12.97M | 9.95M | 6.89M | 4.61M | 2.36M | 288.52K | 122.76K | 131.41K | 245.23K | 267.52K | 847.15K | 454.14K | 158.93K | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 669.47K | 282.87K | 449.95K | 0.00 | 0.00 | 49.11K | 1.06K | 0.00 | 23.54K | 38.68K | 11.31K | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 11.15M | 12.97M | 9.95M | 6.89M | 4.61M | 2.36M | 372.12K | 126.11K | 131.41K | 268.77K | 306.21K | 915.09K | 454.14K | 158.93K | 87.50K | 0.00 |
| Other Expenses | 1.47M | 1.49M | 1.46M | 112.03K | 12.87K | 1.59K | 1.59K | 6.55K | 27.05K | 35.50K | 39.91K | 28.54K | 13.75K | 2.67K | 17.33K | 1.80K |
| Operating Expenses | 13.45M | 14.46M | 11.40M | 7.00M | 4.62M | 3.17M | 372.12K | 126.11K | 267.52K | 267.04K | 434.89K | 1.29M | 467.88K | 161.59K | 104.83K | 1.80K |
| Cost & Expenses | 30.49M | 35.16M | 25.11M | 10.78M | 7.45M | 4.38M | 373.80K | 132.78K | 267.52K | 267.04K | 434.89K | 1.29M | 467.88K | 161.59K | 104.83K | 1.80K |
| Interest Income | 72.00K | 72.00K | 163.56K | 1.12M | 719.87K | 5.62K | 0.00 | 0.00 | 0.00 | 76.00 | 0.00 | 14.00 | 27.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 1.72M | 1.37M | 53.39K | 132.72K | 1.24M | 5.62K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 14.00 | 4.07K | 2.12K | 78.00 | 0.00 |
| Depreciation & Amortization | 1.80M | 1.94M | 2.83M | 582.20K | 291.81K | 8.62K | 1.68K | 6.67K | 27.05K | 35.03K | 35.57K | 24.12K | 13.75K | 2.67K | 0.00 | 0.00 |
| EBITDA | -14.88M | -23.11M | 587.33K | -4.17M | -2.29M | -2.35M | -386.98K | -126.11K | -131.41K | -221.49K | -310.55K | -1.26M | -427.82K | -161.83K | -113.54K | -1.80K |
| EBITDA Ratio | -65.21% | -3.14% | 11.63% | -70.03% | -37.72% | -62.81% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -7.67M | -3.52M | 587.33K | -4.28M | -2.03M | -347.50K | -373.80K | -132.78K | -158.46K | -304.26K | -346.12K | -943.63K | -471.95K | -163.72K | -104.83K | -1.80K |
| Operating Income Ratio | -33.61% | -11.12% | 2.29% | -80.98% | -44.00% | -14.40% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -10.48M | -22.89M | -397.08K | 1.08M | -910.15K | -1.54M | -14.86K | 588.33K | -86.51K | 37.30K | -128.68K | -345.79K | 47.75K | -3.00K | -78.00 | 0.00 |
| Income Before Tax | -18.15M | -25.63M | 190.25K | -4.46M | -3.75M | -2.69M | -388.66K | 464.51K | -267.52K | -266.97K | -434.89K | -1.29M | -424.20K | 0.00 | -104.91K | -1.80K |
| Income Before Tax Ratio | -79.55% | -81.03% | 0.74% | -84.43% | -81.37% | -111.30% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 2.17M | 2.59M | 2.17M | 134.17K | 1.34M | -904.72K | -3.09 | -2.98 | 0.00 | 0.00 | 0.00 | 0.00 | 51.81K | 2.12K | 0.00 | 82.48K |
| Net Income | -20.78M | -28.23M | -1.98M | -4.60M | -5.09M | -1.78M | -388.66K | 464.51K | -267.52K | -266.97K | -434.89K | -1.29M | -424.17K | -163.72K | -104.91K | -84.28K |
| Net Income Ratio | -91.07% | -89.22% | -7.69% | -86.97% | -110.34% | -73.81% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.16 | -0.25 | -0.02 | -0.04 | -0.07 | -0.05 | -0.06 | 0.21 | -0.17 | -0.35 | -0.58 | -1.55 | -0.30 | -0.14 | -0.12 | -4.50 |
| EPS Diluted | -0.16 | -0.25 | -0.02 | -0.04 | -0.07 | -0.05 | -0.06 | 0.21 | -0.17 | -0.35 | -0.58 | -1.55 | -0.30 | -0.14 | -0.12 | -4.50 |
| Weighted Avg Shares Out | 134.35M | 112.21M | 108.46M | 102.64M | 69.55M | 38.93M | 6.38M | 2.19M | 1.54M | 764.69K | 744.32K | 830.00K | 1.40M | 1.21M | 857.18K | 18.71K |
| Weighted Avg Shares Out (Dil) | 134.35M | 112.21M | 108.46M | 102.64M | 69.55M | 38.93M | 6.38M | 2.19M | 1.54M | 764.69K | 744.32K | 830.00K | 1.40M | 1.21M | 857.18K | 18.71K |
Body and Mind Announces Delay in Filing Interim Financial Statements
Source: https://incomestatements.info
Category: Stock Reports